Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-15

Clinical Trial Update: Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports the completion of maintenance decitabine after transplantation for patients with acute myeloid leukemia or myelodysplastic syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dacogen (decitabine)
  • Decitabine (Decitabine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED